Long-term survival analysis of masitinib in amyotrophic lateral sclerosis.

MLA

Mora, Jesus S., et al. “Long-Term Survival Analysis of Masitinib in Amyotrophic Lateral Sclerosis.” Therapeutic Advances in Neurological Disorders, July 2021, pp. 1–16. EBSCOhost, https://doi.org/10.1177/17562864211030365.

APA

Mora, J. S., Bradley, W. G., Chaverri, D., Hernández-Barral, M., Mascias, J., Gamez, J., Gargiulo-Monachelli, G. M., Moussy, A., Mansfield, C. D., Hermine, O., & Ludolph, A. C. (2021). Long-term survival analysis of masitinib in amyotrophic lateral sclerosis. Therapeutic Advances in Neurological Disorders, 1–16. https://doi.org/10.1177/17562864211030365

Chicago

Mora, Jesus S., Walter G. Bradley, Delia Chaverri, María Hernández-Barral, Javier Mascias, Josep Gamez, Gisella M. Gargiulo-Monachelli, et al. 2021. “Long-Term Survival Analysis of Masitinib in Amyotrophic Lateral Sclerosis.” Therapeutic Advances in Neurological Disorders, July, 1–16. doi:10.1177/17562864211030365.